Evolve Private Wealth LLC Makes New Investment in Molina Healthcare, Inc $MOH

Evolve Private Wealth LLC acquired a new stake in Molina Healthcare, Inc (NYSE:MOH) in the first quarter, HoldingsChannel reports. The institutional investor acquired 2,475 shares of the company’s stock, valued at approximately $330,000.

Other large investors also recently modified their holdings of the company. Hsbc Holdings PLC boosted its holdings in Molina Healthcare by 54.9% in the fourth quarter. Hsbc Holdings PLC now owns 193,104 shares of the company’s stock valued at $33,687,000 after purchasing an additional 68,448 shares during the last quarter. Rockefeller Capital Management L.P. increased its holdings in Molina Healthcare by 76.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,134 shares of the company’s stock worth $197,000 after purchasing an additional 492 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of Molina Healthcare by 64.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 232 shares of the company’s stock valued at $40,000 after purchasing an additional 91 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its position in shares of Molina Healthcare by 10.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after purchasing an additional 201,772 shares in the last quarter. Finally, Invesco Ltd. boosted its stake in shares of Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock valued at $293,453,000 after buying an additional 329,679 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Stock Performance

MOH stock opened at $229.81 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. The firm has a market cap of $11.97 billion, a P/E ratio of 67.99 and a beta of 0.80. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $311.52. The stock’s 50 day simple moving average is $186.48 and its 200 day simple moving average is $168.34.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the previous year, the company posted $6.08 earnings per share. The firm’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities research analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Transactions at Molina Healthcare

In related news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on MOH. Truist Financial raised their price target on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, May 2nd. Wells Fargo & Company raised their price objective on shares of Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a report on Monday, April 27th. Sanford C. Bernstein reissued an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th. Finally, Weiss Ratings upgraded shares of Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and a consensus target price of $184.81.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.